Rationale-Cardiac fibrosis contributes to pathogenesis of atrial fibrillation (AF), which is the most sustained arrhythmia and a major cause of morbidity and mortality. Although it has been suggested that Ca 2+ signals are involved in fibrosis promotion, the molecular basis of Ca 2+ signaling mechanisms and how Ca 2+ signals contribute to fibrogenesis remain unknown.
INTRODUCTION
Cardiac fibrosis is a detrimental factor that results in abnormalities in cardiac conduction, stiffening of the ventricular walls, and loss of contractility, thereby contributing to a variety of heart diseases, including hypertrophy, heart failure, and arrhythmia 1 . Atrial fibrillation (AF) is the most sustained clinical arrhythmia and is a major cause of morbidity and mortality 2 . Recent studies have demonstrated that structural remodeling as a result of fibrosis is one of the fundamental mechanisms underlying the perpetuation of AF, and contributes synergistically with electrical and contractile remodeling to AF substrate [2] [3] [4] [5] [6] . Atrial fibrosis is a hallmark feature of arrhythmogenic structural remodeling in clinical AF 7 . Increased amount of fibrosis occurs in not only AF patients associated with other cardiac diseases 8, 9 , but also in those with lone AF 8, 10 . There is a positive correlation between the amounts of fibrosis and the persistence of AF 9 , suggesting that atrial fibrosis results in structural remodeling to promote AF. The causal importance of fibrosis in occurrence and persistence of AF is strongly supported by studies in animal models in which selective atrial fibrosis caused by overexpression of TGF-β1 increases AF vulnerability 11, 12 . Thus, understanding the mechanism of fibrogenesis is important in developing new therapeutic strategies aimed at preventing or reversing structural remodeling in AF.
Fibrosis represents excessive deposition of extracellular matrix proteins (ECM) synthesized by cardiac fibroblasts or myofibroblasts upon stimulation 13, 14 . Myofibroblasts are not found in normal cardiac tissue 15 . In response to pathological stimuli, such as myocardial injury, oxidative stress, mechanical stretch, autocrine-paracrine mediators, and inflammatory stimuli, fibroblasts proliferate, migrate and undergo phenotypic changes and differentiate into myofibroblasts 14, 16 . Myofibroblasts might also be derived from endothelial cells in fibrotic heart 17 . By producing growth factors, cytokines, chemokines, ECM proteins, and proteases 18, 19 , myofibroblasts play a pivotal role in fibrosis. Inhibition of myofibroblast differentiation may prove to be a common and effective approach to attenuate cardiac fibrosis, regardless of the initial stimuli. However, little is known about the molecular mechanisms underlying fibroblast differentiation.
Ca 2+ signals are essential for diverse cellular functions including differentiation, gene expression, cell proliferation, growth and death 20 . In cardiac fibroblasts, several lines of evidence suggest that Ca 2+ entry is essential for fibroblast functions. Chelating external Ca 2+ by EGTA prevents substance P induced proliferation of cultured rat cardiac fibroblasts 21, 22 . Eliminating external Ca 2+ to prevent Ca 2+ influx attenuates H 2 O 2 induced IL-6 mRNA expression 23 . In mechanical-stimulation or stretch-induced membrane potential studies, both Ca 2+ -entry and Ca 2+ -release are involved in generation of MIP (MIP: mechanically induced potential) 24, 25 . A stretch induced current can be blocked by Gadlinium (Gd 3+ ) 26 , a non-selective cation channel blocker. Recently, it has been shown that intracellular Ca 2+ contributes to Angiotensin II (Ang II) induced proliferation of cardiac fibroblasts 27 . In an in vivo study, Mibefradil, a Ca 2+ channel blocker, significantly reduced collagen production and fibroblast differentiation in rats treated with AngII or Aldosterone 28 . These studies indicate that Ca 2+ entry through Ca 2+ -permeable ion channels is essential for gene expression and fibrosis promotion. Therefore, understanding the molecular basis of Ca 2+ -permeable channels is crucial for elucidating the molecular mechanisms of proliferation and differentiation of cardiac fibroblasts.
Fibroblasts have been reported to have depolarized resting membrane potentials. Measured by standard microelectrode techniques in multicellular tissues, the resting membrane potential of atrial fibroblasts is between -31 to -16 mV [29] [30] [31] . There is no evidence indicating that functional voltage-gated calcium channels exist in the fibroblast 32 . The transient receptor potential (TRP) channels are responsible for Ca 2+ entry in various non-excitable and excitable cells [33] [34] [35] . TRP channels are non-voltage gated but are activated by a variety of different stimuli including receptor activation, oxidative stress, mechanical stretch, cell metabolites, and thermal or sensory stimuli [33] [34] [35] . TRP channels also enable individual cells to sense changes in their local environment. Given that cardiac fibroblasts encounter a variety of pathological conditions, it seems that TRP channels could be the potential candidates for Ca 2+ signaling in cardiac fibroblasts.
In order to understand Ca 2+ signaling mechanisms in cardiac fibroblasts and potential roles of Ca 2+ signals in the cardiac fibrogenesis cascade, we investigated the molecular basis of Ca 2+ -permeable channels in human atrial fibroblasts isolated from AF patients and normal sinus rhythm patients (NSR), and studied how Ca 2+ influx contributes to TGF-β1 induced fibrogenesis process. We discovered that TRPM7, a Ca 2+ -permeable cation channel which also possesses protein kinase function [36] [37] [38] , underlies the Ca 2+ signaling mechanism in human atrial fibroblasts. TRPM7 has been reported to play a vital role in embryonic development 39 and anoxic cell death 40 . We found that TRPM7 is the major Ca 2+ -permeable channel in human atrial fibroblasts. Knocking down TRPM7 by shRNA largely eliminates the endogenous TRPM7 currents as well as Ca 2+ influx in atrial fibroblasts. Strikingly, TRPM7 and TRPM7-medaited Ca 2+ influx are drastically up-regulated in fibroblasts from AF patients. In addition, inhibition of TRPM7-mediated Ca 2+ influx renders fibroblasts less sensitive to TGF-β1 induced proliferation and differentiation, indicating that TRPM7-mediated Ca 2+ signal is necessary for TGF-β1 elicited fibrogenesis. On parallel with myofibroblast differentiation, TRPM7 is up-regulated by TGF-β1 in cultured fibroblasts. Taken together, our results indicate that TRPM7-mediated Ca 2+ signal contributes to fibroblast differentiation and may mediate the fibrogenic effect of TGF-β1. This study suggests that inhibition of TRPM7 may prove to be an effective approach to reduce fibroblast differentiation and therefore attenuate fibrosis during human AF.
METHODS

Human Cardiac Tissue Sample Collection and fibroblasts isolation
Myocardial samples of the right atria were collected during cardiac surgery. All procedures involving human tissue use were approved by the institutional review boards of the University of Connecticut Health Center. Atrial fibroblasts were isolated by collagenase (see details in the supplementary methods). Freshly isolated fibroblasts from AF and NSR patients were used for patch-clamp experiment to compare the TRPM7 current amplitude.
Molecular Biology
RT-PCR was performed as we previously reported 41 by using the primers shown in Online  Table II . TRPM7-specific shRNAs were designed and constructed into lenti-viral delivery system. The efficiency of the shRNAs was tested in the TRPM7 over-expression HEK-293 cells. The one with higher efficiency was used in the experiments (see the Online Data Supplement)
Electrophysiology
Whole-cell and single-channel currents were recorded as we reported previously 42, 43 . Internal Mg 2+ -free solution was used for whole-cell current recording and inside-out configuration was applied for single channel current recording. For details, see the Online Data Supplement.
Ratio Ca 2+ imaging experiments
Ca 2+ influx was measured using ratio Ca 2+ imaging system and analyzed using NISElements (Nikon). The F340/F380 ratio in the presence of 20 mM Ca 2+ was normalized to that of 1 μM Ionomycin (Iono) elicited Ca 2+ signal (see details in supplementary methods). Ca 2+ influx was also measured with/without store depletion by 2 μM thapsigargin (Tg) in some experiments as specified in text.
Immunostaining
Fibroblasts were fixed by 4% formaldehyde and immmunostained with α-SMA antibody. The immunostained cells were analyzed using a Zeiss LSM 510 confocal microscope. Details are described in the Online Data Supplement.
Western Blot
The protein expression levels of TRPM7 and α-SMA were evaluated by Western blot experiments. GAPDH was used as a loading control (the Online Data Supplement).
Data Analysis
Pooled data are presented as mean ± SEM. Dose-response curves were fitted by an equation of the form E=E max {1/[1+(EC 50 /C) n ]}, where E is the effect at concentration C, E max is maximal effect, EC 50 is the concentration for half-maximal effect and n is the Hill coefficient. Statistical comparisons were made using two-way ANALYSIS of variance (ANOVA) and two-tailed t-test with Bonferroni correction. Fisher's exact test was used for analysis of percentage differences for patients' database. P < 0.05 indicated statistical significance.
RESULTS
TRPM7 is the major Ca 2+ -permeable channel in human atrial fibroblasts
To understand which Ca 2+ permeable channel is responsible for Ca 2+ entry in cardiac fibroblasts, we first investigated the expression of Ca 2+ -permeable TRP channels. Among the 27 human TRP channel genes 33 , we found that TRPM7 is abundantly expressed in human atrial fibroblasts (Online Figure I) . To study whether TRPM7 constitutes functional channels in the fibroblasts, we applied voltage-clamp to investigate the current characteristics. As shown in Figure 1 , a TRPM7-like current was readily elicited by a voltage ramp protocol ranging from -120 to +100 mV. The current-voltage relation (I-V relation) with small inward current and strong outward rectification ( Figure 1A ) is similar to the typical characteristics of the recombinant TRPM7 36, 37 . Heterologous expressed TRPM7 exhibits several unique features, including single channel conductance, potentiation by low external pH, inhibition by low concentrations of 2-aminoethoxydiphenyl borate (2-APB) but potentiation by high concentration of 2-APB 43, 44 . We then tested if the endogenous TRPM7-like current in cardiac fibroblasts has similar properties. The single channel conductance of TRPM7-like current ( Figure 1B ) is similar to that of TRPM7 overexpressed in CHO cells 43 . TRPM7-like current was significantly potentiated by low extracellular pH ( Figure 1C ) with an EC 50 of 3.9 pH unit (Online Figure IIB) . Like TRPM7, TRPM7-like current was inhibited by low concentrations of 2-APB with an IC 50 of 32.1 μM (Figure 1E-F) . High concentrations of 2-APB enhanced TRPM7-like current ( Figure 1E ), but the concentration-dependence of the effect was not assessed because of poor solubility of 2-APB at high concentrations. All of these features of the endogenous TRPM7-like currents in human atrial fibroblasts are indistinguishable from those of exogenously expressed TRPM7 42, 43 , suggesting that the TRPM7-like current in the human cardiac fibroblasts is encoded by TRPM7.
To further confirm that TRPM7 constitutes TRPM7-like currents, we applied TRPM7-specific shRNA to the fibroblasts (Figure 2 ). The efficiency of TRPM7-shRNA was first examined in HEK-293 cells over-expressing human TRPM7 (Figure 2A-B) . The current amplitude of TRPM7 was decreased by ~70% after TRPM7-shRNA treatment. Similarly, after treatment for 5 days, the current amplitude of TRPM7-like currents in human fibroblasts was significantly reduced by TRPM7-shRNA in comparison with the cells treated with Scr-shRNA ( Figure 2C -D), indicating that TRPM7 is indeed the molecule encoding TRPM7-like currents in human atrial fibroblasts. Based on these findings, we refer to the TRPM7-like currents as "TRPM7" in the following text.
TRPM7 is responsible for Ca 2+ entry in human atrial fibroblasts
We next asked whether TRPM7 is responsible for Ca 2+ entry in atrial fibroblasts. Using ratio Ca 2+ imaging measurements, we found that Ca 2+ influx was decreased by 62% after fibroblasts were treated with TRPM7-shRNA for 5 days, indicating that TRPM7 is the major Ca 2+ -permeable channel in human atrial fibroblasts ( Figure 2E -F). To elucidate whether there are other Ca 2+ -permeable channels which may contribute to Ca 2+ influx in human atrial fibroblasts, we used the conditions specific for TRPV2 45 , TRPV4 46 or TRPC6 47, 48 current recording, and tested if functional currents of these channels are present in human atrial fibroblasts. As shown in Figure 3 , TRPV2-like currents could not be elicited by 200 μM 2-APB in human atrial fibroblasts ( Figure 3A ), whereas 2-APB readily activated TRPV2 overexpressed in HEK293 cells ( Figure 3B -C). The conditions used for activating TRPV4 expressed in HEK293 cells ( Figure 3E -F) failed to induce any TRPV4-like current in atrial fibroblasts. TRPC6 can be elicited by activation of G q -like receptor activation ( Figure 3H -I). However, neither using LPA to activate EDG7 receptor ( Figure 3G ) nor including GTPγS in the pipette solution (Online Figure III) was effective in inducing TRPC6-like current in atrial fibroblasts. These results, summarized in Figure 3 , indicate that TRPV2, TRPV4, and TRPC6 do not constitute functional currents even though their expression was detectable by RT-PCR (Online Figure I) . Therefore, it is unlikely that TRPV2, TRPV4 or TRPC6 contribute to Ca 2+ entry in human atrial fibroblasts.
It appears that TRPC1 is abundantly expressed at mRNA level (Online Figure I ) in human atrial fibroblasts. Since TRPC1 may form heteromeric channels with TRPC4 or TRPC5 49 , we attempted to record heteromeric currents with I-V relations similar to those of TRPC1/ TRPC4 (or TRPC1/TRPC5). However, including GTPγs in the pipette solution failed to induce any TRPC1/TRPC4-or TRPC1/TRPC5-like current (data not shown), suggesting that TRPC1 may not be able to form functional heteromeric channels in atrial fibroblasts. Knocking down hTRPC1 by TRPC1 siRNA did not influence Ca 2+ influx or fibroblast differentiation (Online Figure IV) , further indicating that TRPC1 may not be able to contribute Ca 2+ influx in human atrial fibroblasts.
We next investigated whether store depletion-activated Ca 2+ channel (I CRAC ) may influence Ca 2+ entry in atrial fibroblasts. As shown in Figure 5 , store-depletion by 5 μM thapsigargin (Tg) did not induce any current, suggesting that store depletion activated channels are not functionally expressed in human atrial fibroblasts. Moreover, Ca 2+ influx was not changed by Tg, further suggesting that store-depletion does not contribute to Ca 2+ signals in human atrial fibroblasts. We also investigated whether TRPV2, TRPV4, TRPC1/TRPC4, TRPC6 and I CRAC currents are present in fibroblasts from AF patients, and found that TRPM7 current is the only current that we were able to record in fibroblasts from both NSR and AF patients. Therefore, it appears that endogenous TRPM7 is the major channel which mediates Ca 2+ entry in human atrial fibroblasts.
TRPM7 is markedly up-regulated in atrial fibroblasts from AF patients
It has been shown that fibrosis associated structural remodeling is a major contributor to AF 7 . However, the Ca 2+ signaling mechanism in fibrogenesis is unknown. Our findings that TRPM7 is the major Ca 2+ -permeable channel in human atrial fibroblasts provided us an excellent opportunity to explore how Ca 2+ signals are involved in fibrosis associated AF. The left atrial size of AF patients was similar to that in NSR patients among those enrolled in the current study (Online Table I ), although a larger group of AF and NSR patients, including those who were not enrolled in the fibroblast study, showed a larger left atrial size in the AF vs. NSR patients (data not shown). We used freshly isolated fibroblasts from biopsy specimens for current recording. This eliminated cell culture related factors which could interfere with the experimental results. We found that TRPM7 currents recorded from freshly isolated fibroblasts in AF patients were 3-to 5-fold larger than those from NSR patients (Figure 4 ). Both inward and outward currents were increased significantly. Since measurement of outward current amplitude gives a more accurate assessment, we used outward current amplitude measured at +100 mV for comparison ( Figure 4C-D) . The average TRPM7 current density was 32.5 ± 2.3 pA/pF in fibroblasts from AF patients (88 cells from 7 patients) and 11.1±0.5 pA/pF in fibroblasts from NSR patients (87 cells from 8 patients), respectively. The increase in TRPM7 current density appears to be resulted from increased membrane expression of TRPM7 channel proteins, as the single channel conductance and open probability of TRPM7 were indistinguishable between the NSR fibroblasts and AF fibroblasts (Online Figure VI) . We were not able to do western blot experiments to determine TRPM7 protein levels in NSR and AF fibroblasts due to the limited amount of tissues and limited number of fibroblasts. However, we observed that whereas we were able to obtained single channel recordings from more than 95% of patches in the AF fibroblasts, less than 50% of patches from NSR fibroblasts displayed single channel openings, suggesting that membrane protein level of TRPM7 was higher in AF fibroblasts than that in NSR fibroblasts.
To study if the increased TRPM7 currents result in enhanced Ca 2+ influx, we used ratio Ca 2+ imaging method to compare the Ca 2+ entry through TRPM7 in fibroblasts isolated from AF and NSR patients. Since TRPM7 channels conduct small inward currents and are constitutively active, we used 20 mM Ca 2+ in order to obtain better signal/noise ratio. In addition, cells were briefly exposed to a nominally divalent free solution (DVF) in order to eliminate any blockade of TRPM7 by external Mg 2+ . As shown in Figure 5 , the peak Ca 2+ influx in fibroblasts from AF patients was 10-fold greater than Ca 2+ influx in the fibroblasts from NSR patients. This result not only further indicates that TRPM7 is the major Ca 2+ -permeable channel responsible for Ca 2+ influx in human atrial fibroblasts, but also strongly implies that TRPM7-mediated Ca 2+ signals may play an important role in AF-associated fibrogenesis.
TRPM7 is required for differentiation of human atrial fibroblasts
As the myofibroflast is the major cell type that synthesizes growth factors, cytokines, chemokines, and extracellular matrix (ECM) proteins, and plays a pivotal role in fibrogenesis 13, 19 , we tested whether there was a higher percentage of myofibroblasts in the cells isolated from atrial samples from AF patients than those from NSR patients. As shown in Figure 6 , after 24 hrs culture, without TGF-β1 treatment, cells from AF patients displayed 44% myofibroblasts, whereas only 16% cells from NSR patients were myofibroblats. Such data suggest that fibroblasts from AF patients are more prone to differentiation into myofibroblasts. The increased vulnerability to differentiation in the fibroblasts from AF patients might result from an up-regulated TRPM7 level. After TGF-β1 (10 ng/ml) induction, 90% of fibroblasts differentiated into myofibroblasts in both NSR and AF groups.
To determine the contribution of TRPM7 to basal differentiation of fibroblasts from AF patients, AF fibroblasts were treated with TRPM7-shRNA or Scr-shRNA in 1% FBS media after atrial fibroblasts attached to the coverslips (by culturing for 12 hrs in 10% FBS media) for 72 hrs. Fibroblasts were then cultured in 10% FBS media for 24 hr, followed by Ca 2+ influx and differentiation assessment. As shown in Figure 6C -D, TRPM7-shRNA significantly decreased Ca 2+ influx and inhibited basal AF fibroblast differentiation, indicating that TRPM7-mediated Ca 2+ entry contributes to basal differentiation of AF fibroblasts.
We further investigated whether TRPM7 is involved in TGF-β1 induced differentiation. Human atrial fibroblasts from NSR patients were treated with TRPM7-shRNA and scramble shRNA (Scr-shRNA). TGF-β1 was then applied to induce differentiation after cells were serum starved for 24 hours. As shown in Figure 7 , without TGF-β1 (10 ng/ml) treatment, there were 30.0% myofibroblasts in the Scr-shRNA treated group and 25.4% myofibroblasts in the TRPM7-shRNA treated group. This higher basal differentiation of NSR fibroblasts in comparison with that in Fig. 6 was due to that the fibroblasts were culture in 10% FBS media for more than 84 hrs, and there is a time-dependent increase in basal differentiation rate when fibroblasts were cultured in 10% FBS media (Online Figure VII) . After TGF-β1 stimulation, the differentiated myofibroblasts in the Scr-shRNA treated group increased to 61.0%, whereas, knocking down of TRPM7 by TRPM7-shRNA significantly reduced the differentiated myofibroblasts to 34.4%, a level similar to the control group ( Figure 7B ). The loss of sensitivity to TGF-β1 in TRPM7-shRNA treated fibroblasts suggests that TRPM7 plays a role in TGF-β1 induce atrial fibroblast differentiation.
To understand how TRPM7 may be involved in fibroblast differentiation, we quantified changes of α-SMA protein in scramble-and TRPM7-shRNA treated cells by Western blot. This experiment was performed by using mouse fibroblasts due to the limited number of human fibroblasts. To rule out other factors such as residual TGFβ 50 in serum which may influence differentiation, we applied the TGF-β1 receptor blocker SB431542 as a control for TGF-β1 treatment. As shown in Figure 7C , the increased protein expression of α-SMA induced by TGF-β1 was significantly reduced by TRPM7 shRNA, which is consistent with the immunostaining result in human fibroblasts (Figure 7A-B) .
Role of TRPM7 in TGF-β1 induced fibroblast proliferation
We next investigated the role of TRPM7 in proliferation of fibroblasts. Human cardiac fibroblasts treated with scramble or TRPM7-shRNA were exposed to TGF-β1 (10 ng/ml). As shown in Figure 7D , TRPM7-shRNA significantly decreased the number of fibroblasts, suggesting that TRPM7 is also involved in cardiac fibroblast proliferation caused by TGF-β1.
Regulation of TRPM7 by TGF-β1
As TGF-β1 is the most potent fibrogenesis stimulator, we studied whether expression of TRPM7 is modulated by TGF-β1. In this experiment, fibroblasts were treated with TGF-β1 or the TGF-β1 receptor blocker SB431542. TRPM7 currents were recorded after the human atrial fibroblasts were treated for 24 hr. As shown in Figure 8A -B, TRPM7 current density was increased by about 80% by TGF-β1. Ca 2+ -influx in TGF-β1 treated fibroblasts was significantly larger than that of control group (Online Figure VIII) . Consistent with the increased current amplitude, TRPM7 expression at mRNA level assessed by qPCR using mouse cardiac fibroblasts was increased by 2.8 fold. Although other Ca 2+ -permeable channel genes were also up-regulated by TGF-β1 (Online Figure IX) , TRPM7 is the only functional channel which can be measured by current recording in human atrial fibroblasts (Figure 2-3 ) and in mouse fibroblasts before and after after TGF-β1 treatment (data not shown). Moreover, knocking down the abundantly expressed TRPC1 did not alter Ca 2+ influx or differentiation of human atrial fibroblasts (Online Figure IV) . Therefore, it is likely that TRPM7 plays a major role in mediating Ca 2+ in atrial fibroblasts under normal conditions and upon TGF-β stimulation. To further understand the correlation between the changes of TRPM7 induced by TGFβ1 and fibroblast differentiation, we tested TRPM7 protein and α-SMA expression levels by using mouse cardiac fibroblasts. Figure 8C -D shows that TGF-β1 increased TRPM7 and α-SMA protein expression by 3.8-and 2.1-fold, respectively. The mRNA level of collagen (type I) as well as collagen production measured in human atrial fibroblasts was markedly increased by TGF-β1 (Fig. 8E-F) . These results further suggest that up-regulation of TRPM7 underlies the Ca 2+ signaling mechanism for TGF-β1 induced fibroblast differentiation and collagen production, and that TRPM7 may play a role in TGF-β1 induced atrial fibrogenesis.
DISCUSSION
To our knowledge, this is the first study to report a pathophysiological function of the Ca 2+ -permeable cation channel TRPM7 in human disease. We made several new findings in this study. First, our results reveal that TRPM7 underlies the molecular mechanism of Ca 2+ signaling in human atrial fibroblasts. Second, we demonstrate that TRPM7 mediated Ca 2+ plays an essential role in atrial fibroblasts proliferation and differentiation. Third, we show that TRPM7 is markedly up-regulated in AF patients, and that up-regulation of TRPM7 confers increased fibroblast differentiation in AF patients. Our results suggest that TRPM7 mediated Ca 2+ may play a pivotal role in fibrogenesis in human AF.
TRPM7 underlies the molecular mechanism of Ca 2+ signaling in human atrial fibroblasts
Ca 2+ signals are essential for various cellular functions. Although the importance of fibrosis in various cardiac diseases has been well appreciated, the Ca 2+ signaling mechanisms in cardiac fibrogenesis are not known. Here we demonstrate that TRPM7 is abundantly expressed in human atrial fibroblasts, and is the major Ca 2+ -permeable channel which is responsible for Ca 2+ influx in human atrial fibroblasts.
TRPM7 is a Ca 2+ -permeable cation channel 36, 37 . It is constitutively active and brings Ca 2+ into cells under physiological conditions. High intracellular Mg 2+ concentration blocks TRPM7. However, TRPM7 channels show ~50% of their maximum activity at physiological Mg 2+ levels (0.5-1 mM) 36, 51 . Extracellular low pH potentiates TRPM7 inward current 42 , and oxidative stress activates TRPM7 40 . Membrane stretch 52 and shear stress 38 have been reported to activate TRPM7. All of these characteristics of TRPM7 suggest that TRPM7 plays a role under pathological conditions, such as ischemia or oxidative stress, which may initiate the cardiac fibrogenesis cascade.
Our results indicate that TRPM7 is encoded by TRPM7 and that TRPM7 is the major functional Ca 2+ -permeable channel in human atrial fibroblasts. Although TRPV2, TRPV4, TRPC1 and TRPC6 were detectable by RT-PCR, current recording results indicate that there were no functional TRPV2, TRPV4 or TRPC6 channels in the fibroblasts, making them unlikely to contribute to Ca 2+ signaling in the fibroblasts. TRPV4 is sensitive to stretch 53 , and can be specifically activated by 4α-PDD. We found that in both freshly isolated and cultured fibroblasts, 4α-PDD was unable to activate TRPV4-like currents ( Figure 3 ). TRPC6 is activated by G q -linked receptor stimulation, DAG or OAG, or by direct application of GTPγS in the pipette solution. We could not activate TRPC6-like current by LPA, which activates the EDG7 receptor 54 , or by including GTPγS in the pipette solution (Online Figure III) . These results indicate that TRPC6 is not functionally expressed in human atrial fibroblasts. A previous study reported that TRPC6 was activated by C-type natriuretic peptide through PLC activation or directly by OAG in rat cardiac fibroblasts 48 . We do not know the reason for this discrepancy, but human and rat cardiac fibroblasts may express TRPC6 differently.
Store-depletion activated Ca 2+ current (I CRAC ) contributes to Ca 2+ influx and plays an important role in cellular functions in a variety of cells 55, 56 . In human atrial fibroblasts, we could not detect I CRAC currents, and did not find that store-depletion could induce Ca 2+ influx (Online Figure V) in human atrial fibroblasts. I CRAC , TRPV2, TRPV4, TRPC1 and TRPC6 currents were not present in AF fibroblasts. Even though we found that TGF-β1 upregulates mRNA expression of TRPM7, TRPV2, TRPC1, TRPC3, TRPC4 and TRPC6 (Online Figure IX) , TRPM7 current is the only functional current recorded in the fibroblasts treated with TGF-β1, suggesting that TRPM7 is the major channel mediating Ca 2+ entry in atrial fibroblasts. When TRPM7 was knocked down, Ca 2+ influx was substantially decreased in TRPM7-shRNA treated atrial fibroblasts in comparison with Scr-shRNA treated atrial fibroblasts, indicating that TRPM7 is needed for Ca 2+ entry in fibroblasts. Taken together, our results indicate that TRPM7 is the major Ca 2+ -permeable channel which is responsible for Ca2+ influx in human atrial fibroblasts.
Up-regulation of TRPM7 may underlie TGF-β1 induced fibroblast differentiation in AF patients
We found that TRPM7 is markedly up-regulated in the fibroblasts from AF patients. Both current density and Ca 2+ influx mediated by TRPM7 from AF patients were significantly larger than those from NSR patients (Figure 4) . Due to the limited amount of tissue and numbers of human atrial fibroblasts, we could not compare the TRPM7 expression in AF and NSR patients by measuring protein levels using Western Blot. Since the only differences between AF patients and NSR patients is the presence of atrial fibrillation versus normal sinus rhythm (Online Table I ), it appears that atrial fibrillation is the only variable that correlates with the up-regulated TRPM7. To understand the causal importance of TRPM7 in AF, we investigated whether TRPM7 influences fibroblast differentiation. We found that fibroblasts isolated from AF patients are more prone to differentiation under culture conditions even without TGF-β1 treatment. This inherent tendency to differentiation could be due to the increased expression level of TRPM7 when the fibroblasts were exposed to the residual amount of TGFβ in the culture media containing serum 50 . Indeed, knockingdown TRPM7 by TRPM7-shRNA not only markedly reduced basal differentiation of AF fibroblasts (Fig. 6C-D) , but also substantially decreased the number of differentiated myofibroblasts and the expression level of α-SMA induced by TGF-β1, indicating that TRPM7 is necessary for fibroblast differentiation. As the myofibroblasts are the primary cells that synthesize ECM and cytokines, which in turn stimulate the fibrogenesis cascade, the requirement of TRPM7 for myofibroblast differentiation indicates that TRPM7 mediated Ca 2+ signals play a pivotal role in fibrosis formation.
Fibrogenesis can be triggered by various stimuli, including mechanical stretch, oxidative stress, hormones, myocardial injury, and autocrine-paracrine mediators 14, 16 , among which TGF-β1 is the most potent stimulator in both in vivo and in vitro conditions. Interestingly, we found that TRPM7 expression was significantly increased by TGF-β1 in cultured fibroblasts (Figure 8 ). The increased TRPM7 expression level induced by TGF-β1 parallels the fibroblast differentiation as assessed by α-SMA expression and collagen production ( Figure 8C-F) . These results indicate that TRPM7 is indispensable for TGF-β1 induced differentiation, and that the up-regulated TRPM7 may synergize with TGFβ1 in inducing fibroblast differentiation. It is possible that the up-regulation of TRPM7 by TGF-β1 in cultured fibroblasts represents the major mechanism by which TRPM7 is up-regulated in AF patients in vivo. Taken together, our results suggest the following model: In human atria, TGF-β1 is activated by mechanical stretch, oxidative stress, or other stimuli. TGF-β1 upregulates TRPM7, which in turn brings more Ca 2+ for TGF-β1 to induce differentiation. The differentiated myofibroblasts synthesize ECM and cytokines, and excessive accumulation of ECM forms fibrosis. Cytokines can in turn stimulate TGF-β1 and cause up-regulation of TRPM7, leading to perpetuation of the fibrogenesis process.
Potential mechanism by which Ca 2+ signals are involved in TGF-β1 induced fibrosis
Atrial fibrosis plays an important role in the pathology of AF. Although three interrelated pathways including the renin-angiotensin system, TGF-β1 and the oxidative stress pathways have been shown to be involved in fibrosis [57] [58] [59] [60] [61] [62] [63] , many fundamental aspects of fibrogenesis are still to be established 6, 57 . Our results indicate that TRPM7-mediated Ca 2+ signal is another fundamental factor contributing to atrial fibrogenesis cascade.
How does the Ca 2+ signal contribute to fibrosis formation? There are several possibilities. First, Ca 2+ -dependent but TGF-β1-independent pathways may control fibrotic gene expression [64] [65] [66] [67] . Second, Ca 2+ signals may influence TGF-β1 via the Smad-independent pathway [68] [69] [70] . Third, TGF-β1 can induce Ca 2+ entry 71, 72 or integrate with reactive oxygen species (ROS) associated Ca 2+ influx and therefore influence ECM protein synthesis 73 through a ROS activated calcineurin pathway. As TRPM7 can be activated by ROS 40 , it is possible that the ROS activated calcineurin pathway may have contributed to the upregulation of TRPM7 by TGF-β1 in human atrial fibroblasts. Fourth, TRPM7-mediated Ca 2+ signals may activate the calcineurin pathway and produce synergistic effect with TGF-β1 (Smad-dependent pathway) in regulating gene expression. Further studies are required to understand how TRPM7 mediated Ca 2+ signals contribute to TGF-β1 induced fibrogenesis. Nevertheless, our findings that TRPM7 is the molecular basis for the major Ca 2+ entry channel in cardiac fibroblasts provide a necessary tool to unravel the mechanisms by which Ca 2+ signals contribute to fibrogenesis.
Potential significance
Atrial fibrosis can be triggered by various factors 13 via different pathways 57 . Blocking one pathway may not be able to attenuate or eliminate fibrosis given the complex pathological conditions. The TRPM7-mediated Ca 2+ signals which are necessary for TGF-β1 induced fibrogenesis may serve as a common pathway in the fibrogenesis cascade. If so, inhibition of Ca 2+ entry through TRPM7 may attenuate cardiac fibrosis regardless of the original stimuli.
TRPM7 has been shown to be essential for cell viability 74, 75 and is responsible for Ca 2+ overload induced cell death under anoxia conditions 40 . Although previous studies suggested that TRPM7 is involved in Mg 2+ homeostasis 74, 76 , knocking out of the TRPM7 gene disrupts embryonic development but does not alter Mg 2+ homeostasis 39 , indicating that Ca 2+ permeation may confer major channel functions of TRPM7. The contribution of the TRPM7-mediated Ca 2+ signal in human atrial fibrogenesis shown in this study is the first demonstration of an important role of this unique channel in human diseases.
Conclusions
In this study, we establish that the Ca 2+ -permeable cation channel TRPM7 underlies Ca 2+ signaling mechanisms in the cardiac fibrogenesis, making TRPM7 the first known Ca 2+ -permeable channel involved in the genesis of cardiac fibrosis. More importantly, our results demonstrate that TRPM7 plays an essential role in fibrogenesis in human AF. Our study opens a new avenue to explore the potential roles of Ca 2+ signaling in fibrogenesis, which will lead to better understanding of the mechanism of cardiac fibrogenesis, and could ultimately results in development of more effective approaches for treatment of AF.
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NOVELTY AND SIGNIFICANCE
What is known?
• Atrial fibrosis is a hallmark feature of structural remodeling in atrial fibrillation (AF).
• Previous studies have suggested that Ca 2+ entry is essential for fibroblast function. However, the Ca 2+ signaling mechanisms in cardiac fibrogenesis have not elucidated.
What new information does this article contribute?
• Here we report that the Ca 2+ -permeable cation channel TRPM7 is the major Ca 2+ -permeable channel in human atrial fibroblasts.
• TRPM7-mediated Ca 2+ entry is essential for TGF-β1-induced fibroblast differentiation.
• TRPM7 is significantly up-regulated in AF fibroblasts and plays a key role in enhanced fibroblast proliferation, differentiation, and collagen production during AF.
Summary
Atrial fibrosis is a major factor contributing to AF. Understanding the mechanism of fibrogenesis is crucial for developing new therapeutic strategies for attenuating or reversing fibrosis-associated AF. The aim of this study was to elucidate the Ca 2+ signaling mechanisms in fibroblasts and how Ca 2+ signals contribute to fibrogenesis in AF. We discovered that TRPM7, a Ca 2+ -permeable cation channel that possesses protein kinase function, is the key Ca 2+ -permeable channel in human atrial fibroblasts. TRPM7 and TRPM7-mediated Ca 2+ signals were drastically up-regulated in AF patients, which correlated with enhanced fibrogenesis in cells from these patients. This study identifies for the first time the molecular nature of the major Ca 2+ -permeable channel in cardiac fibroblasts, which helps to elucidate how Ca 2+ signals contribute to fibrogenesis in human AF. Also, our observation that TRPM7-mediated Ca 2+ entry contributes to human AF represents the first report of an important role of TRPM7 in human diseases. Our study opens a new avenue to explore the potential role of Ca 2+ signals in fibrogenesis, which should lead to better understanding of the mechanisms of cardiac fibrogenesis and could ultimately result in the development of more effective approaches for the treatment of AF.
Non-standard Abbreviations and Acronyms
AF
Atrial Fibrillation
NSR
Normal sinus rhythm
TRPM7
Transient receptor potential melastatin related 7
TRP
Transient receptor potential
TRPV2
Transient receptor potential V2
TRPV4
Transient receptor potential V4
TRPC6
Transient receptor potential C6
CABG
Coronary Artery Bypass Graft
AngII Angiotensin II
2-APB 2-Aminoethoxydiphenyl borate
TGF-β1
Transforming growth factor β1 The endogenous TRPM7-like channels in human atrial fibroblasts resemble the characteristics of recombinant TRPM7. A, Representative TRPM7-like currents elicited by a voltage ramp protocol ranging from -120 to +100 mV. B, Single channel conductance of TRPM7-like channel was 38.4 ± 1.6 pS (n=6). Representative recordings from inside-out patches are shown in the inset. C, TRPM7-like inward current was potentiated by external acidic pH solution. D, Concentration-dependent effects of external protons on TRPM7-like currents. E, Biphasic effects of 2-APB on TRPM7-like currents, with inhibition and potentiation at low and high 2-APB concentrations, respectively. F, Concentrationdependent inhibition of 2-APB on TRPM7-like currents. Best fit with Hill equation yielded IC 50 =32.1 ± 0.1 μM, n H =1.1 (mean ± SEM, n=5). TRPM7 underlies the molecular basis of the TRPM7-like channel and that TRPM7-like channel mediated Ca 2+ entry constitutes the major Ca 2+ influx in human atrial fibroblasts. A, Typical recordings of TRPM7 over-expressed in HEK-293 cells after treatment with scramble (Scr)-shRNA and TRPM7-shRNA. B, Average current amplitude of TRPM7. TRPM7-shRNA decreased TRPM7 by about 70%. C, Current amplitude of TRPM7-like current recorded in human atrial fibroblasts in a TRPM7-specific shRNA treated cell (Blue) in comparison with that of a Scr-shRNA treated cell (Red). D, Mean current density of TRPM7-like current in TRPM7-shRNA and Scra-shRNA treated cells. E, Ca 2+ influx mediated by TRPM7-like channel. Ca 2+ influx was elicited by 20 mM Ca 2+ . The amplitude of Ca 2+ influx was normalized to the peak Ca 2+ influx induced by 1 μM Ionomycin (Iono). Up-regulation of endogenous TRPM7 in atrial fibroblasts from AF patients. A, Typical TRPM7 recording in a freshly isolated fibroblast from AF patient. B, TRPM7 recorded in a freshly isolated fibroblast from NSR patient. C, Average current density of TRPM7 from each AF and NSR patient. Note that current amplitudes from all the AF patients are larger than the biggest current amplitude in NSR patients. D, Average current density of endogenous TRPM7 from all the fibroblasts in AF and NSR patients. Increased Ca 2+ influx in AF fibroblasts in comparison with that in NSR fibroblasts. A, Changes of F340/F380 ratio under indicated conditions. There was more Ca 2+ influx in the fibroblasts from AF patients when the cells were perfused with 20 mM Ca 2+ . Ca 2+ influx was measured after the fibroblasts were cultured for 12 hrs which allows fibroblasts to attach to the coverslips. B, Normalized F340/F380 ratio from a representative experiment using the cells from AF and NSR patients. C, Average ratio of F340/F380 in fibroblasts from AF and NSR patients. The ratio was normalized to the maximal response induced by 1 μM ionomycin. Myofibroblast differentiation in cells from AF and NSR patients. A, Immunostaining with antibody against α-SMA in fibroblasts from NSR and AF patients, respectively. Fibroblasts from AF patients show a higher percentage of differentiated myofibroblasts in the absence of TGF-β1treatment (P <0.01). TGF-β1(10 ng/ml) treatment induced 90% differentiated myofibroblasts in cells from both AF and NSR patients. α-SMA is in red, and nuclei are labeled in blue by TO-PROIII. B, Mean percentage of differentiated myofibroblasts in AF or NSR patients with or without TGF-β1treatment. The basal differentiation (without TGFβ1treatment) in AF patients is higher than that in NSR patients (P <0.01). C, TRPM7-shRNA decreased Ca 2+ inlux in atrial fibroblasts from AF patient . The average decrease of Ca 2+ influx by TRPM7-shRNA was 64%. D, The basal differentiation of atrial fibroblasts from AF patient was significantly decreased by TRPM7-shRNA. Effects of TRPM7 on fibroblast differentiation and proliferation. A, Differentiated myofibroblasts detected by immunostaining of α-SMA (Red). Human atrial fibroblasts were isolated from NSR patients and treated with Scr-or TRPM7-shRNA. Differentiation was induced by 10 ng/ml TGF-β1. Differentiation percentage was obtained by counting the number of differentiated cells (Red) divided by the total number of cells as identified by the nuclei (Blue). B, Average percentage of differentiated myofibroblasts in Scr-or TRPM7-shRNA treated cells. In TRPM7-shRNA treated cells, differentiation induced by TGF-β1was not significantly different from that of cells without TGF-β1 induction (34.4 ± 7.2% and 23.5± 4.8% respectively; p >0.05). In Scr-shRNA treated cells, the differentiation induced by TGF-β1 (61.0 ± 1.9%) was significantly higher than that in control cells (30.4 ± 6.1%). C, Changes in α-SMA induced by 10 ng/ml TGF-β1 in TRPM7-or Scr-shRNA treated mouse cardiac fibroblasts. TGFβ receptor blocker SB431542 (10 μM) was applied to the control groups to minimize differentiation at basal level. α-SMA protein identified by α-SMA antibody; GAPDH was used as loading control. Please note the significant decrease of α-SMA in TRPM7-shRNA treated cells. Similar results were obtained in three separate experiments. D, Effects of TRPM7-shRNA on human atrial fibroblast proliferation induced by TGF-β1 (10 ng/ml). Up-regulation of TRPM7 by TGF-β1. A, Representative recording of TRPM7 in control human atrial fibroblasts and in fibroblasts treated with 10 ng/ml TGF-β1. B, Average current amplitude of TRPM7 after TGF-β1 treatment in comparison with control cells. The current density was 8.9 ± 1.2 (n=25) pA/pF in control and 15.6 ± 1.7 (n=26) pA/pF in TGF-β1 treated group. C, Up-regulation of TRPM7 by TGF-β1 evaluated in mouse cardiac fibroblasts. Top: western blot results of TRPM7 in control and TGF-β1 treated groups; Middle: expression of α-SMA in control and TGF-β1treated groups; Bottom: GAPDH used as loading control. D, Average increase in TRPM7 and α-SMA expression induced by TGF-β1. TRPM7 protein expression was increased by 3.8 ± 0.9 fold (n=4) and α-SMA was increased by 2.1 ± 0.6 fold (n=4). E-F, Increased collagen production in human atrial fibroblasts induced by TGF-β1 evaluated at mRNA (E) and protein (F) levels. Average data were from three separate experiments.
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